An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer.
about
Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapyHypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization.A novel chimeric promoter that is highly responsive to hypoxia and metals.Can gene therapy overcome the problem of hypoxia in radiotherapy?Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic.Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model.A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy.Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy.Hypoxia/hepatoma dual specific suicide gene expression plasmid delivery using bio-reducible polymer for hepatocellular carcinoma therapy.A novel hybrid promoter responsive to pathophysiological and pharmacological regulationLister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours.Robust hypoxia-selective regulation of a retinal pigment epithelium-specific adeno-associated virus vectorEnhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements.A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.Effect of hypoxia on Ad5 infection, transgene expression and replication.Hypoxia-inducible transgene expression in differentiated human NT2N neurons--a cell culture model for gene therapy of postischemic neuronal loss.A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.Oxygen tension and a pharmacological switch in the regulation of transgene expression for gene therapy.Selective killing of cancer cells based on translational control of a suicide gene.Novel chimeric gene promoters responsive to hypoxia and ionizing radiation.Hypoxia-mediated tumour targeting.The macrophage - a novel system to deliver gene therapy to pathological hypoxia.Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemia.Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells.The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment.
P2860
Q24797919-BA0414BC-3B4C-4800-8694-9F8C18B71F62Q30939880-44D8A079-119B-4A0F-9365-85E0E7AEE964Q33233475-C26AD0F5-B172-4D27-9C98-E98A880D38C4Q34157875-3250491B-6DEA-45A5-9169-AE488C64DDD7Q34319721-37D74069-DEFE-454D-8AD6-EA0DB4FA4737Q34679148-5F14DAD6-9191-4A08-A99F-193F911BD0F2Q34779805-AD148B47-D45A-4B3B-BC5B-D199971E7DB6Q37137456-CEAF3E93-812C-4E4C-BFA2-278869C32806Q37489674-85689370-46F7-4C48-AC4A-96E675FB13E7Q39450777-210FF244-B2A7-4FE1-9990-6E4B833406FCQ39778777-55857B3D-AB00-4DF0-8D8E-67CEEEB52B23Q40003426-F08B71BC-0F9A-491A-A64E-2D3F06CDAE76Q40338070-85E49C77-0C8E-4B24-AA24-AFA794CD3A28Q40432513-C24A67A8-86DF-4B59-8405-B3A3ED7FED27Q40462233-3E0DDE2C-BA84-4829-80F6-FD8854C23036Q40778617-E6AEEA29-F9A6-47E5-A683-E9BB0B31A25DQ41817953-D9B2A997-A15A-4185-9C8B-3BB8BACA86A2Q43767321-9B2F34DE-C38F-4BBD-B0E2-758921BD12A0Q44040165-9B8FDC22-4B08-43A1-9950-329533446A5CQ44168577-AF193F41-83EA-471F-8DCE-C98E6A800E0AQ44368762-179BAD71-DB94-4403-9420-AE46AC93598DQ45865618-B99A33D5-FA14-4BE1-B1AE-BCA7B8D1E5FDQ45868433-BA68FA39-D5E9-4F52-B523-C1AE8A10E03BQ45882286-C7B1049E-88D3-4713-AA8A-22374883BD2DQ45882787-DE06E1EA-6A13-4C62-B4D8-4B3E115087ACQ47215309-9D75FF6B-AF19-4E30-ABEA-F96FEB6824A3
P2860
An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
An adenoviral vector regulated ...... ischaemic disease and cancer.
@en
An adenoviral vector regulated ...... ischaemic disease and cancer.
@nl
type
label
An adenoviral vector regulated ...... ischaemic disease and cancer.
@en
An adenoviral vector regulated ...... ischaemic disease and cancer.
@nl
prefLabel
An adenoviral vector regulated ...... ischaemic disease and cancer.
@en
An adenoviral vector regulated ...... ischaemic disease and cancer.
@nl
P2093
P2860
P921
P356
P1433
P1476
An adenoviral vector regulated ...... ischaemic disease and cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301001
P577
1999-10-01T00:00:00Z
P5875
P6179
1019305249